logo

For the Inventor, By the Inventor

Lawrence, KS, United States of America

Gere S diZerega

This inventor holds 15 USPTO granted patents and 9 published patent applications and 2 EPO patents, primarily in Cancer Treatment. Top assignees: Crititech, Inc., Critltech, Inc.. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gere S diZerega. Retrieved from https://idiyas.com/inventor/gere-s-dizerega-7wgbfdkn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 58(Granted Patents)


Company Filing History:

goldMedal14 out of 33 
 
Crititech, Inc.
 patents
silverMedal1 out of 1 
 
Critltech, Inc.
 patent

Years Active: 2019-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Antineoplastic Particles
Immunotherapeutic Agents
Solid Tumor Treatment
Epithelial Cysts
Intracystic Injection
Lung Disorders
Local Delivery
Systemic Delivery
15 patents (USPTO):Explore Patents
1. 12329858 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2025-06-17),
2. 12128131 - Treatment of epithelial cysts by intracystic injection of antineoplastic particles (2024-10-29),
3. 11918691 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2024-03-05),
4. 11737972 - Treatment of epithelial cysts by intracystic injection of antineoplastic particles (2023-08-29),
5. 11583499 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2023-02-21),
6. 11523983 - Treatment of epithelial cysts by intracystic injection of antineoplastic particles (2022-12-13),
7. 11458133 - Methods for solid tumor treatment (2022-10-04),
8. 11160754 - Methods for treating lung disorders (2021-11-02),
9. 11058639 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2021-07-13),
10. 11033542 - Methods for solid tumor treatment (2021-06-15),
11. 10894045 - Methods for solid tumor treatment (2021-01-19),
12. 10874660 - Methods for solid tumor treatment (2020-12-29),
13. 10507181 - Methods for treating lung disorders (2019-12-17),
14. 10398646 - Methods for treating lung disorders (2019-09-03),
15. 10391090 - Methods for solid tumor treatment (2019-08-27),

Title: The Innovative Contributions of Gere S diZerega

Introduction

Gere S diZerega is a prominent inventor based in Lawrence, Kansas, known for his significant contributions to the field of cancer treatment. With a total of 15 patents to his name, diZerega has focused on developing innovative methods for delivering therapeutic agents to combat cancer effectively.

Latest Patents

Among his latest patents, diZerega has disclosed methods for the local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer. This combination therapy aims to enhance the therapeutic effects by utilizing local administration techniques such as topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection. Another notable patent involves the treatment of epithelial cysts through intracystic injection of antineoplastic particles, including taxane particles like paclitaxel and docetaxel.

Career Highlights

Throughout his career, diZerega has worked with various companies, including Crititech, Inc. and Critltech, Inc. His work has been instrumental in advancing cancer treatment methodologies, showcasing his dedication to improving patient outcomes through innovative solutions.

Collaborations

Some of his notable coworkers include Charles J Decedue and Sam Campbell, who have contributed to his research and development efforts in the field.

Conclusion

Gere S diZerega's innovative work in cancer treatment through his patents and collaborations highlights his commitment to advancing medical science. His contributions continue to pave the way for new therapeutic approaches in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…